Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD

Weill Cornell Medicine (WCM)

Status: Enrolling

Conditions: Caregiver Burden

Treatments: Other: I-HoME

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06488157

23-01025643

K76AG059997-04S1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.

Enrollment: 15 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years old and < 100 years
• English speaking
• Providing care to an ADRD patient who is age ≥ 65 years old and < 105 years who is a stage 7a-f on the Functional Assessment Staging Tool (FAST) scale

Exclusion criteria

• Non-English speaking
• <18 years old or >100 years old

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Intervention (I-HoME)

Experimental group

Description:

Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs.

Treatment:

Other: I-HoME